Edwards Lifesciences Corp 8-K

What Happened

• Edwards Lifesciences Corporation (EW) announced its first-quarter 2026 financial results. The company furnished a press release reporting those results on April 23, 2026, via a Form 8-K (Item 2.02).

Key Details

• Filing date: April 23, 2026 (Form 8-K, Item 2.02).
• Subject: Financial results for the quarter ended Q1 2026 (first quarter 2026).
• Press release: Furnished as Exhibit 99.1 to the Form 8-K.
• Interactive data: Inline XBRL cover page data furnished as Exhibit 104.

Why It Matters

• Quarterly results provide updated information on Edwards’ earnings, revenue and operating performance that investors use to evaluate the company’s near-term health and compare to guidance or analyst expectations.
• The press release and XBRL data give investors and analysts the official figures and machine-readable disclosures needed to update models and make investment decisions.